MF3 - Tuberculosis

download MF3 - Tuberculosis

of 41

Transcript of MF3 - Tuberculosis

  • 7/30/2019 MF3 - Tuberculosis

    1/41

    Tuberculosis

    By:

    Laurence Gerard A. Aberia

    06.22.2013

  • 7/30/2019 MF3 - Tuberculosis

    2/41

    Case of JZ

    36 y/o unmarried man from RI

    Recently released from state prison

    Does carpentry for a living

    Lives with a distant cousin in abungalow

  • 7/30/2019 MF3 - Tuberculosis

    3/41

    Case of JZ

    Complained of the ff at the ER:

    1.)Hemoptysis secondary to persistent

    coughing over the last month

    2.) Pain during exhalation and inhalation

    3.) Fatigue

    4.) Decreased appetite

  • 7/30/2019 MF3 - Tuberculosis

    4/41

    Introduction

    Tuberculosis (TB) is caused by bacteria of theMycobacterium tuberculosis complex

    Lungs are usually affected although other

    organs may be involved as well

    One of the oldest diseases known to affecthumans

    Remains to be one of the major causes ofdeath worldwide

  • 7/30/2019 MF3 - Tuberculosis

    5/41

    Etiology

    M. tuberculosis is a rod-shaped, non-spore-forming,thin aerobic bacteriummeasuring 0.5 m by 3 m.

    Acid-fast bacilli

    Complete genomesequence ofM. tuberculosiscomprises 4043 genesencoding 3993 proteins and50 genes encoding RNAs

    High guanine + cytosinecontent (65.6%) is indicativeof an aerobic lifestyle.

  • 7/30/2019 MF3 - Tuberculosis

    6/41

    Epidemiology

    More than 2B (1/3 of world pop.) areestimated to be infected with TB

    Most cases come from developing countriesin Asia, Africa, and in the Middle East

    Global incidence peaked around 2003 and

    now appears to be declining slowly

    In 20108.8M ill; 1.4M died

  • 7/30/2019 MF3 - Tuberculosis

    7/41

    Epidemiology

    Commonlytransmitted bydroplet nuclei whichare aerosolized by

    coughing, sneezing,or speaking

    There may be as

    many as 3000infectious nuclei percough

  • 7/30/2019 MF3 - Tuberculosis

    8/41

    Epidemiology

    Determinants of transmission:

    1.) Probability of contact

    2.) Intimacy & duration of contact3.) Degree of infectiousness

    4.) Shared environment

  • 7/30/2019 MF3 - Tuberculosis

    9/41

    Epidemiology

    Pts whose sputum contains AFB visible bymicroscopy are the most likely to transmitthe infection

    Most infectious pts: pts who have cavitarypulmonary disease, and pts who havelaryngeal TB

    Pts with extrapulmonary disease arenonifectious

  • 7/30/2019 MF3 - Tuberculosis

    10/41

    Epidemiology

    The risk of developing disease depends largely on theindividuals innate immunologic and nonimmunologicdefenses

    Clinical illness directly following infection: Primary TB

    common among children & immunocompromisedpersons

    Primary TB is not generally associated with high-leveltransmissibility despite its severity

    Dormant bacilli: Secondary TB / Postprimary TB

    Secondary TB is more infectious b/c of frequentcavitation

  • 7/30/2019 MF3 - Tuberculosis

    11/41

    Pathogenesis and Immunity

    Inhalation of nuclei containing microorganismfrom infectious pt: signals the interaction ofM.tuberculosis with the human host

    Complex series of events happen that ensurethe survival of the bacilli within thephagosomes

    If the bacilli are successful in arrestingphagosome maturation, replication begins

  • 7/30/2019 MF3 - Tuberculosis

    12/41

    What makes TB so dangerous?

    C N C

    Coalesce

    Necrosis

    Cavity

  • 7/30/2019 MF3 - Tuberculosis

    13/41

    Clinical Manifestations

    TB may be classified as:

    Pulmonary

    Extrapulmonary

    Both pulmonary and extrapulmonary

  • 7/30/2019 MF3 - Tuberculosis

    14/41

    Clinical Manifestations

    Pulmonary TB

    Primary Disease Occurs soon after the

    initial infection withtubercle bacilli

    Middle and lower lungzones are involved

    Lesions formed are

    peripheral

    May progress rapidly toclinical illness

    Postprimary Disease Results from endogenous

    reactivation of latentinfection

    Localized to the apicaland posterior segmentsof the upper lobe

    A.K.A: Adult-type

    Reactivation

    Secondary TB

  • 7/30/2019 MF3 - Tuberculosis

    15/41

    Clinical Manifestations

    Extrapulmonary TB

    In order of frequency, theextrapulmonary sites most commonlyinvolved in tuberculosis are:

    Lymph nodes Pleura

    Genitourinary tract

    Bones & Joints

    Meninges Peritoneum

    Pericardium

  • 7/30/2019 MF3 - Tuberculosis

    16/41

    Clinical Manifestations

    Extrapulmonary TB: Lymph-Node

    Presents as painless swelling of thelymph nodes, most commonly atposterior cervical and supraclavicular

    sitesscrofula (lymphadenitis)

    Most common type of EPTB

    Frequent among HIV-infected patients

  • 7/30/2019 MF3 - Tuberculosis

    17/41

    Clinical Manifestations

    Extrapulmonary TB: Pleura

    Result from either:

    contiguous spread of parenchymal

    inflammation

    accompanying postprimary disease,

    actual penetration by tubercle bacilli into

    the pleural space

  • 7/30/2019 MF3 - Tuberculosis

    18/41

    Clinical Manifestations

    Extrapulmonary TB: Upper Airways

    A complication of advanced cavitarypulmonary tuberculosis

    may involve the larynx, pharynx, andepiglottis

    Symptoms include: hoarseness, dysphonia, and dysphagia

    productive cough

  • 7/30/2019 MF3 - Tuberculosis

    19/41

    Clinical Manifestations

    Extrapulmonary TB: Genitourinary

    involve any portion of the genitourinarytract

    Common presentations: urinaryfrequency, dysuria, nocturia, hematuria,and flank or abdominal pain

    Pts may be asymptomatic

    Female > Male

  • 7/30/2019 MF3 - Tuberculosis

    20/41

    Clinical Manifestations

    Extrapulmonary TB: Skeletal

    In bone and joint disease, spread fromadjacent paravertebral lymph nodes

    Weight bearing joints are mostcommonly affected

  • 7/30/2019 MF3 - Tuberculosis

    21/41

    Clinical ManifestationsExtrapulmonaryTB: Meningitis and Tuberculoma

    Results from the hematogenous spread ofprimary or postprimary pulmonarydisease or from the rupture of asubependymal tubercle into the

    subarachnoid space

    Paresis of cranial nerves

    Lumbar puncture is the cornerstone ofdiagnosis

  • 7/30/2019 MF3 - Tuberculosis

    22/41

    Clinical Manifestations

    Extrapulmonary TB: Gastrointestinal

    Uncommon

    Various pathogenetic mechanisms are

    involved: Swallowing of sputum with direct seeding Hematogenous spread Ingestion of milk from cows affected by

    bovine tuberculosis

    Ileum and Cecum are the most commonsites involved

  • 7/30/2019 MF3 - Tuberculosis

    23/41

    Clinical Manifestations

    Extrapulmonary TB: Pericardial

    Often a disease of the elderly andthose with HIV

    Due to direct progression of a primaryfocus within the pericardium, toreactivation of a latent focus, or torupture of an adjacent subcarinallymph node

  • 7/30/2019 MF3 - Tuberculosis

    24/41

    Clinical ManifestationsExtrapulmonaryTB: Miliary/Disseminated

    Due to hematogenous spread oftubercle bacilli

    Lesions: yellowish granulomas thatresemble millet seeds

    Eye examination may reveal choroidal

    tubercles

    Rare presentation seen in the elderly:cryptic miliary TB, which has a chronic

    course involvement preceding death

  • 7/30/2019 MF3 - Tuberculosis

    25/41

    Clinical Manifestations

    Extrapulmonary TB: HIV associated

    Common occurrence among HIVpatients

    A new tuberculosis infection acquiredby an HIV-infected individual mayevolve to active disease in a matter of

    weeks rather than months or years

  • 7/30/2019 MF3 - Tuberculosis

    26/41

    Diagnosis of TB

    The diagnosis is first entertained whenthe chest radiograph of a patient isabnormal

  • 7/30/2019 MF3 - Tuberculosis

    27/41

    Diagnosis of TBAFB Microscopy

    Based on the finding of AFB onmicroscopic examination of adiagnostic specimen, such as a smear

    of expectorated sputum or of tissue

  • 7/30/2019 MF3 - Tuberculosis

    28/41

    Diagnosis of TBMycobacterial

    Culture

    Specimens may be inoculated ontoegg or agar-based medium andincubated at 37*C

    48 weeks before growth is detected

  • 7/30/2019 MF3 - Tuberculosis

    29/41

    Diagnosis of TBNucleic Acid

    Amplification

    Permit the diagnosis of tuberculosis inas little as several hours, with highspecificity and sensitivity approaching

    that of culture

    most useful for the rapid confirmation

    of tuberculosis in persons with AFB-positive specimens

  • 7/30/2019 MF3 - Tuberculosis

    30/41

    Diagnosis of TBDrug

    Susceptibility Testing

    Initial isolate ofM. tuberculosis shouldbe tested for susceptibility to isoniazid,rifampin, and ethambutol

    Conducted directly (with the clinicalspecimen) or indirectly (with

    mycobacterial cultures) on solid orliquid medium

  • 7/30/2019 MF3 - Tuberculosis

    31/41

    Diagnosis of TBRadiographic

    Procedures

    Abnormal chest radiographs

    The classic picture is that of upper lobe

    disease with infiltrates and cavities

    CT for questionable findings on plain

    chest radiography

    MRI for intracranial TB

  • 7/30/2019 MF3 - Tuberculosis

    32/41

    Diagnosis of TBTuberculin Skin

    Testing

    Used in screening for latent TB infection

    Positive result: firm red bump at the sitew/in 2 days

    How its done: Injection of small amount of TB protein on

    the top layer of the skin on inner forearm

  • 7/30/2019 MF3 - Tuberculosis

    33/41

    Management

    Two aims of TB treatment:

    1.) Interrupt TB transmission by rendering pts

    nonifectious

    2.) Prevent morbidity and death by curing

    pts with TB

  • 7/30/2019 MF3 - Tuberculosis

    34/41

    Management

    Four major drugs are considered the first-line agents for the treatment of TB:1.) isoniazid2.) rifampin

    3.) pyrazinamide4.) ethambutol

    Well absorbed after oral administration

    69 months regimen

  • 7/30/2019 MF3 - Tuberculosis

    35/41

    Management

    isoniazid, rifampin, pyrazinamide, andethambutol were chosen on the basisof their:

    1.) bactericidal activity

    2.) sterilizing activity

    3.) low rate of induction of drugresistance

  • 7/30/2019 MF3 - Tuberculosis

    36/41

    Management

    Bacteriologic evaluation is thepreferred method of monitoring theresponse to treatment for TB

    Pts with pulmonary disorders: sputumexamination until it becomes negative

    Pts with extrapulmonary tuberculosis:difficult and often not feasible

  • 7/30/2019 MF3 - Tuberculosis

    37/41

    Management

    Some strains of TB that becomeresistant to drugs arise by spontaneouspoint mutations in the mycobacterial

    genome

    Drug resistant TB: occurs at a low, but

    predictable rate

  • 7/30/2019 MF3 - Tuberculosis

    38/41

    Management

    During treatment, pt should bemonitored fordrug toxicity

    Common adverse effect: hepatitis

    Hypersensitive reactions usually requirethe discontinuation of all drugs

  • 7/30/2019 MF3 - Tuberculosis

    39/41

    Management

    Treatment failure: suspected when aptssputum culture remains positiveafter3 months, or if AFB smears remain

    positive after 5 months

    The mycobacterial strains infecting pts

    who experience relapse afterapparent successful treatment are lesslikely to have acquired drug resistance

  • 7/30/2019 MF3 - Tuberculosis

    40/41

    Management

    Best way to prevent TB: diagnose andisolate infectious cases rapidly andadminister treatment until pts are

    rendered noninfectious

  • 7/30/2019 MF3 - Tuberculosis

    41/41

    OT Management

    Arts and crafts